» Articles » PMID: 8114692

A New Orphan Member of the Nuclear Hormone Receptor Superfamily That Interacts with a Subset of Retinoic Acid Response Elements

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1994 Mar 1
PMID 8114692
Citations 140
Authors
Affiliations
Soon will be listed here.
Abstract

We have identified and characterized a new orphan member of the nuclear hormone receptor superfamily, called MB67, which is predominantly expressed in liver. MB67 binds and transactivates the retinoic acid response elements that control expression of the retinoic acid receptor beta 2 and alcohol dehydrogenase 3 genes, both of which consist of a direct repeat hexamers related to the consensus AGGTCA, separated by 5 bp. MB67 binds these elements as a heterodimer with the 9-cis-retinoic acid receptor, RXR. However, MB67 does not bind or activate other retinoic acid response elements with alternative hexamer arrangements or any of several other wild-type and synthetic hormone response elements examined. The transactivation of retinoic acid response elements by MB67 is weaker than that conferred by the retinoic acid receptors but does not require the presence of all-trans retinoic acid, 9-cis-retinoic acid, or any exogenously added ligand. We propose that MB67 plays an important role in the complex network of proteins that govern response to retinoic acid and its metabolites.

Citing Articles

Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management.

Rondanelli M, Borromeo S, Cavioni A, Gasparri C, Gattone I, Genovese E Metabolites. 2025; 15(2).

PMID: 39997751 PMC: 11857149. DOI: 10.3390/metabo15020127.


Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer.

Bae S, Nguyen R, Yuen L, Lam V, George J, Qiao L Sci Rep. 2024; 14(1):30926.

PMID: 39730609 PMC: 11680565. DOI: 10.1038/s41598-024-81571-z.


Constitutive androstane receptor: A tumor suppressor and a biomarker for favorable prognosis of liver diseases.

Bae S, Nguyen R, Yuen L, Lam V, George J, Qiao L Genes Dis. 2024; 11(6):101198.

PMID: 39157456 PMC: 11327506. DOI: 10.1016/j.gendis.2023.101198.


Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets.

Fleishman J, Kumar S Signal Transduct Target Ther. 2024; 9(1):97.

PMID: 38664391 PMC: 11045871. DOI: 10.1038/s41392-024-01811-6.


Regulation of PXR in drug metabolism: chemical and structural perspectives.

Gee R, Huber A, Chen T Expert Opin Drug Metab Toxicol. 2024; 20(1-2):9-23.

PMID: 38251638 PMC: 10939797. DOI: 10.1080/17425255.2024.2309212.


References
1.
Williams G, Harney J, Moore D, Larsen P, Brent G . Differential capacity of wild type promoter elements for binding and trans-activation by retinoic acid and thyroid hormone receptors. Mol Endocrinol. 1992; 6(10):1527-37. DOI: 10.1210/mend.6.10.1333048. View

2.
Lydon J, Power R, Conneely O . Differential modes of activation define orphan subclasses within the steroid/thyroid receptor superfamily. Gene Expr. 1992; 2(3):273-83. PMC: 6057375. View

3.
Leid M, Kastner P, Chambon P . Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci. 1992; 17(10):427-33. DOI: 10.1016/0968-0004(92)90014-z. View

4.
Brent G, Dunn M, Harney J, Gulick T, Larsen P, Moore D . Thyroid hormone aporeceptor represses T3-inducible promoters and blocks activity of the retinoic acid receptor. New Biol. 1989; 1(3):329-36. View

5.
Sladek F, Zhong W, Lai E, Darnell Jr J . Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 1990; 4(12B):2353-65. DOI: 10.1101/gad.4.12b.2353. View